- •Hematuria II: causes and investigation
- •Hematospermia
- •Lower urinary tract symptoms (LUTS)
- •Nocturia and nocturnal polyuria
- •Flank pain
- •Urinary incontinence in adults
- •Genital symptoms
- •Abdominal examination in urological disease
- •Digital rectal examination (DRE)
- •Lumps in the groin
- •Lumps in the scrotum
- •2 Urological investigations
- •Urine examination
- •Urine cytology
- •Radiological imaging of the urinary tract
- •Uses of plain abdominal radiography (KUB X-ray—kidneys, ureters, bladder)
- •Intravenous pyelography (IVP)
- •Other urological contrast studies
- •Computed tomography (CT) and magnetic resonance imaging (MRI)
- •Radioisotope imaging
- •Post-void residual urine volume measurement
- •3 Bladder outlet obstruction
- •Regulation of prostate growth and development of benign prostatic hyperplasia (BPH)
- •Pathophysiology and causes of bladder outlet obstruction (BOO) and BPH
- •Benign prostatic obstruction (BPO): symptoms and signs
- •Diagnostic tests in men with LUTS thought to be due to BPH
- •Why do men seek treatment for their symptoms?
- •Watchful waiting for uncomplicated BPH
- •Medical management of BPH: combination therapy
- •Medical management of BPH: alternative drug therapy
- •Minimally invasive management of BPH: surgical alternatives to TURP
- •Invasive surgical alternatives to TURP
- •TURP and open prostatectomy
- •Indications for and technique of urethral catheterization
- •Indications for and technique of suprapubic catheterization
- •Management of nocturia and nocturnal polyuria
- •High-pressure chronic retention (HPCR)
- •Bladder outlet obstruction and retention in women
- •Urethral stricture disease
- •4 Incontinence
- •Causes and pathophysiology
- •Evaluation
- •Treatment of sphincter weakness incontinence: injection therapy
- •Treatment of sphincter weakness incontinence: retropubic suspension
- •Treatment of sphincter weakness incontinence: pubovaginal slings
- •Overactive bladder: conventional treatment
- •Overactive bladder: options for failed conventional therapy
- •“Mixed” incontinence
- •Post-prostatectomy incontinence
- •Incontinence in the elderly patient
- •Urinary tract infection: microbiology
- •Lower urinary tract infection
- •Recurrent urinary tract infection
- •Urinary tract infection: treatment
- •Acute pyelonephritis
- •Pyonephrosis and perinephric abscess
- •Other forms of pyelonephritis
- •Chronic pyelonephritis
- •Septicemia and urosepsis
- •Fournier gangrene
- •Epididymitis and orchitis
- •Periurethral abscess
- •Prostatitis: presentation, evaluation, and treatment
- •Other prostate infections
- •Interstitial cystitis
- •Tuberculosis
- •Parasitic infections
- •HIV in urological surgery
- •6 Urological neoplasia
- •Pathology and molecular biology
- •Prostate cancer: epidemiology and etiology
- •Prostate cancer: incidence, prevalence, and mortality
- •Prostate cancer pathology: premalignant lesions
- •Counseling before prostate cancer screening
- •Prostate cancer: clinical presentation
- •PSA and prostate cancer
- •PSA derivatives: free-to-total ratio, density, and velocity
- •Prostate cancer: transrectal ultrasonography and biopsies
- •Prostate cancer staging
- •Prostate cancer grading
- •General principles of management of localized prostate cancer
- •Management of localized prostate cancer: watchful waiting and active surveillance
- •Management of localized prostate cancer: radical prostatectomy
- •Postoperative course after radical prostatectomy
- •Prostate cancer control with radical prostatectomy
- •Management of localized prostate cancer: radical external beam radiotherapy (EBRT)
- •Management of localized prostate cancer: brachytherapy (BT)
- •Management of localized and radiorecurrent prostate cancer: cryotherapy and HIFU
- •Management of locally advanced nonmetastatic prostate cancer (T3–4 N0M0)
- •Management of advanced prostate cancer: hormone therapy I
- •Management of advanced prostate cancer: hormone therapy II
- •Management of advanced prostate cancer: hormone therapy III
- •Management of advanced prostate cancer: androgen-independent/ castration-resistant disease
- •Palliative management of prostate cancer
- •Prostate cancer: prevention; complementary and alternative therapies
- •Bladder cancer: epidemiology and etiology
- •Bladder cancer: pathology and staging
- •Bladder cancer: presentation
- •Bladder cancer: diagnosis and staging
- •Muscle-invasive bladder cancer: surgical management of localized (pT2/3a) disease
- •Muscle-invasive bladder cancer: radical and palliative radiotherapy
- •Muscle-invasive bladder cancer: management of locally advanced and metastatic disease
- •Bladder cancer: urinary diversion after cystectomy
- •Transitional cell carcinoma (UC) of the renal pelvis and ureter
- •Radiological assessment of renal masses
- •Benign renal masses
- •Renal cell carcinoma: epidemiology and etiology
- •Renal cell carcinoma: pathology, staging, and prognosis
- •Renal cell carcinoma: presentation and investigations
- •Renal cell carcinoma: active surveillance
- •Renal cell carcinoma: surgical treatment I
- •Renal cell carcinoma: surgical treatment II
- •Renal cell carcinoma: management of metastatic disease
- •Testicular cancer: epidemiology and etiology
- •Testicular cancer: clinical presentation
- •Testicular cancer: serum markers
- •Testicular cancer: pathology and staging
- •Testicular cancer: prognostic staging system for metastatic germ cell cancer
- •Testicular cancer: management of non-seminomatous germ cell tumors (NSGCT)
- •Testicular cancer: management of seminoma, IGCN, and lymphoma
- •Penile neoplasia: benign, viral-related, and premalignant lesions
- •Penile cancer: epidemiology, risk factors, and pathology
- •Squamous cell carcinoma of the penis: clinical management
- •Carcinoma of the scrotum
- •Tumors of the testicular adnexa
- •Urethral cancer
- •Wilms tumor and neuroblastoma
- •7 Miscellaneous urological diseases of the kidney
- •Cystic renal disease: simple cysts
- •Cystic renal disease: calyceal diverticulum
- •Cystic renal disease: medullary sponge kidney (MSK)
- •Acquired renal cystic disease (ARCD)
- •Autosomal dominant (adult) polycystic kidney disease (ADPKD)
- •Ureteropelvic junction (UPJ) obstruction in adults
- •Anomalies of renal ascent and fusion: horseshoe kidney, pelvic kidney, malrotation
- •Renal duplications
- •8 Stone disease
- •Kidney stones: epidemiology
- •Kidney stones: types and predisposing factors
- •Kidney stones: mechanisms of formation
- •Evaluation of the stone former
- •Kidney stones: presentation and diagnosis
- •Kidney stone treatment options: watchful waiting
- •Stone fragmentation techniques: extracorporeal lithotripsy (ESWL)
- •Intracorporeal techniques of stone fragmentation (fragmentation within the body)
- •Kidney stone treatment: percutaneous nephrolithotomy (PCNL)
- •Kidney stones: open stone surgery
- •Kidney stones: medical therapy (dissolution therapy)
- •Ureteric stones: presentation
- •Ureteric stones: diagnostic radiological imaging
- •Ureteric stones: acute management
- •Ureteric stones: indications for intervention to relieve obstruction and/or remove the stone
- •Ureteric stone treatment
- •Treatment options for ureteric stones
- •Prevention of calcium oxalate stone formation
- •Bladder stones
- •Management of ureteric stones in pregnancy
- •Hydronephrosis
- •Management of ureteric strictures (other than UPJ obstruction)
- •Pathophysiology of urinary tract obstruction
- •Ureter innervation
- •10 Trauma to the urinary tract and other urological emergencies
- •Renal trauma: clinical and radiological assessment
- •Renal trauma: treatment
- •Ureteral injuries: mechanisms and diagnosis
- •Ureteral injuries: management
- •Bladder and urethral injuries associated with pelvic fractures
- •Bladder injuries
- •Posterior urethral injuries in males and urethral injuries in females
- •Anterior urethral injuries
- •Testicular injuries
- •Penile injuries
- •Torsion of the testis and testicular appendages
- •Paraphimosis
- •Malignant ureteral obstruction
- •Spinal cord and cauda equina compression
- •11 Infertility
- •Male reproductive physiology
- •Etiology and evaluation of male infertility
- •Lab investigation of male infertility
- •Oligospermia and azoospermia
- •Varicocele
- •Treatment options for male factor infertility
- •12 Disorders of erectile function, ejaculation, and seminal vesicles
- •Physiology of erection and ejaculation
- •Impotence: evaluation
- •Impotence: treatment
- •Retrograde ejaculation
- •Peyronie’s disease
- •Priapism
- •13 Neuropathic bladder
- •Innervation of the lower urinary tract (LUT)
- •Physiology of urine storage and micturition
- •Bladder and sphincter behavior in the patient with neurological disease
- •The neuropathic lower urinary tract: clinical consequences of storage and emptying problems
- •Bladder management techniques for the neuropathic patient
- •Catheters and sheaths and the neuropathic patient
- •Management of incontinence in the neuropathic patient
- •Management of recurrent urinary tract infections (UTIs) in the neuropathic patient
- •Management of hydronephrosis in the neuropathic patient
- •Bladder dysfunction in multiple sclerosis, in Parkinson disease, after stroke, and in other neurological disease
- •Neuromodulation in lower urinary tract dysfunction
- •14 Urological problems in pregnancy
- •Physiological and anatomical changes in the urinary tract
- •Urinary tract infection (UTI)
- •Hydronephrosis
- •15 Pediatric urology
- •Embryology: urinary tract
- •Undescended testes
- •Urinary tract infection (UTI)
- •Ectopic ureter
- •Ureterocele
- •Ureteropelvic junction (UPJ) obstruction
- •Hypospadias
- •Normal sexual differentiation
- •Abnormal sexual differentiation
- •Cystic kidney disease
- •Exstrophy
- •Epispadias
- •Posterior urethral valves
- •Non-neurogenic voiding dysfunction
- •Nocturnal enuresis
- •16 Urological surgery and equipment
- •Preparation of the patient for urological surgery
- •Antibiotic prophylaxis in urological surgery
- •Complications of surgery in general: DVT and PE
- •Fluid balance and management of shock in the surgical patient
- •Patient safety in the operating room
- •Transurethral resection (TUR) syndrome
- •Catheters and drains in urological surgery
- •Guide wires
- •JJ stents
- •Lasers in urological surgery
- •Diathermy
- •Sterilization of urological equipment
- •Telescopes and light sources in urological endoscopy
- •Consent: general principles
- •Cystoscopy
- •Transurethral resection of the prostate (TURP)
- •Transurethral resection of bladder tumor (TURBT)
- •Optical urethrotomy
- •Circumcision
- •Hydrocele and epididymal cyst removal
- •Nesbit procedure
- •Vasectomy and vasovasostomy
- •Orchiectomy
- •Urological incisions
- •JJ stent insertion
- •Nephrectomy and nephroureterectomy
- •Radical prostatectomy
- •Radical cystectomy
- •Ileal conduit
- •Percutaneous nephrolithotomy (PCNL)
- •Ureteroscopes and ureteroscopy
- •Pyeloplasty
- •Laparoscopic surgery
- •Endoscopic cystolitholapaxy and (open) cystolithotomy
- •Scrotal exploration for torsion and orchiopexy
- •17 Basic science of relevance to urological practice
- •Physiology of bladder and urethra
- •Renal anatomy: renal blood flow and renal function
- •Renal physiology: regulation of water balance
- •Renal physiology: regulation of sodium and potassium excretion
- •Renal physiology: acid–base balance
- •18 Urological eponyms
- •Index
414 CHAPTER 9 Upper tract obstruction
Pathophysiology of urinary tract obstruction
Effects of obstruction on renal blood flow and ureteric pressure
Acute unilateral obstruction of a ureter (UUO)
This leads to a triphasic relationship between renal blood flow (RBF) and ureteric pressure.
•Phase 1 (up to 1.5 hours post-obstruction): ureteric pressure rises, RBF rises (afferent arteriole dilatation)
•Phase 2 (1.5–5 hours post obstruction): ureteric pressure continues to rise, RBF falls (efferent arteriole vasoconstriction)
•Phase 3 (beyond 5 hours): ureteric pressure falls, RBF continues to fall (afferent arteriole vasoconstriction)
Acute bilateral obstruction of a ureter (BUO) or obstruction of a solitary kidney
•Phase 1 (up to 1.5 hours post-obstruction): ureteric pressure rises, RBF rises (afferent arteriole dilatation)
•Phase 2 (1.5–5 hours post-obstruction): ureteric pressure continues to rise, RBF is significantly lower than that during unilateral ureteric obstruction
•Phase 3 (beyond 5 hours): ureteric pressure remains elevated (in contrast to UUO). By 24 hours, RBF has declined to the same level as or both unilateral and bilateral ureteric obstruction.
In UUO, the decrease in urine flow through the nephron results in a greater degree of Na absorption, so Na excretion falls. Water loss from the obstructed kidney increases.
Release of BUO is followed by a marked natriuresis, increased K excretion, and a diuresis (a solute diuresis). This is due to the following:
•An appropriate (physiological) natriuresis, to excrete excessive Na that is a consequence of BUO
•A solute diuresis from the accumulation of urea in extracellular fluid
•A diminution of the corticomedullary concentration gradient, which is normally established by the countercurrent mechanism of the loop of Henle, and is dependent on maintenance of flow through the nephron. Reduction of flow, as occurs in BUO, reduces the efficiency of the countercurrent mechanism (effectively, the corticomedullary concentration gradient is washed out).
There may also be accumulation of natriuretic peptides (e.g., ANP) during BUO, which contributes to the natriuresis following release of the obstruction.
PATHOPHYSIOLOGY OF URINARY TRACT OBSTRUCTION 415
Likelihood of recovery of renal function after release of obstruction
In dogs with completely obstructed kidneys, full recovery of renal function after 7 days of UUO occurred within 2 weeks of relief of obstruction. After 14 days of obstruction there was a permanent reduction in renal function to 70% of control levels (recovery to this level taking 3–6 months after reversal of obstruction).
There is some recovery of function after 4 weeks of obstruction, but after 6 weeks of complete obstruction there is no recovery. In humans, there is no clear relationship between the duration of BUO and the degree of recovery of renal function after relief of obstruction.
416 CHAPTER 9 Upper tract obstruction
Physiology of urine flow from kidneys to bladder
Urine production by the kidneys is a continuous process. Its transport from the kidneys, down the ureter, and into the bladder occurs intermittently, by waves of peristaltic contraction of the renal pelvis and ureter (peristalsis = wavelike contractions and relaxations). The renal pelvis delivers urine to the proximal ureter. As the proximal ureter receives a bolus of urine it is stretched, and this stimulates it to contract, while the segment of ureter just distal to the bolus of urine relaxes. Thus the bolus of urine is projected distally.
The origin of the peristaltic wave is from collections of pacemaker cells in the proximal-most regions of the renal calyces. In species with multiple calyces, such as humans, there are multiple pacemaker sites in the proximal calyces.
The frequency of contraction of the calyces is independent of urine flow rate (it is the same at high and low flow rates) and it occurs at a higher rate than that of the renal pelvis. Precisely how frequency of contraction of each calyx is integrated into a single contraction of the renal pelvis is not known.
All areas of the ureter are capable of acting as a pacemaker. Stimulation of the ureter at any site produces a contraction wave that propagates proximally and distally from the site of stimulation, but under normal conditions, electrical activity arises proximally and is conducted distally from one muscle cell to another (the proximal most pacemakers are dominant over these latent pacemakers).
Peristalsis persists after renal transplantation and denervation and does not therefore appear to require innervation. The ureter does, however, receive both parasympathetic and sympathetic innervation, and stimulation of these systems can influence the frequency of peristalsis and the volume of urine bolus transmitted.
At normal urine flow, the frequency of calyceal and renal pelvic contractions is greater than that in the upper ureter, and there is a relative block of electrical activity at the UPJ. The renal pelvis fills; the ureter below it is collapsed and empty. As renal pelvic pressure rises, urine is extruded into the upper ureter. The ureteric contractile pressures that move the bolus of urine are higher than renal pelvic pressures.
A closed UPJ may prevent back-pressure on the kidney. At higher urine flow rates, every pacemaker-induced renal pelvic contraction is transmitted to the ureter.
To propel a bolus of urine, the walls of the ureter must coapt (touch). Resting ureteric pressure is ~0–5 cmH2O and ureteric contraction pressures range from 20 to 80 cmH2O.
Ureteric peristaltic waves occur 2–6 times per minute. The VUJ acts as a one-way valve under normal conditions, allowing urine transport into the bladder and preventing reflux back into the ureter.
URETER INNERVATION 417
Ureter innervation
Autonomic
The ureter has a rich autonomic innervation.
•Sympathetic—preganglionic fibers from spinal segments T10 to L2; postganglionic fibers arise from the celiac, aorticorenal, mesenteric, superior and inferior hypogastric (pelvic) autonomic plexuses
•Parasympathetic—vagal fibers via celiac to upper ureter; fibers from S2–4 to lower ureter
The role of ureteric autonomic innervation is unclear. It is not required for ureteric peristalsis (though it may modulate this). Peristaltic waves originate from intrinsic smooth muscle pacemakers located in minor calyces of renal collecting system.
Afferent
•Upper ureter—afferents pass (alongside sympathetic nerves) to T10–L2
•Lower ureter—afferents pass (alongside sympathetic nerves and by way of pelvic plexus) to S2–4.
Afferents subserve stretch sensation from the renal capsule, collecting system of kidney (renal pelvis and calyces), and ureter. Stimulation of the mucosa of the renal pelvis, calyces, and ureter also stimulates nociceptors, the pain felt being referred in a somatic distribution to T8–L2 (kidney T8–L1, ureter T10–L2), in the distribution of the subcostal, iliohypogastric, ileoinguinal, or genitofemoral nerves.
Thus, ureteric pain can be felt in the flank, groin, scrotum or labia, and upper thigh, depending on the precise site in the ureter from which the pain arises.
This page intentionally left blank